Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Diotheris
company
About
Diotheris develops bacterial therapies of the human skin and mucosal microbiome intended to protect against pathogenic bacteria.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Biotechnology,Life Science,Therapeutics
- Founded date
- May 29, 2020
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Diotheris develops bacterial therapies of the human skin and mucosal microbiome intended to protect against pathogenic bacteria.The company's products are based on live bacteria includes NASOFLORE which targets Staphylococcus aureus, enabling the prevention of infections due to major pathogen and protecting patients against biological threats.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Diotheris has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jul 7, 2020 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 7, 2020 | Seed | — | 1 |
InnoBio Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Diotheris is funded by 1 investors.
InnoBio Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
InnoBio Fund
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
